We are live on ! Find out more
RI

Ridgewood Investments Portfolio holdings

AUM $267M
This Fund
S&P 500
This Quarter Est. Return
-14.14%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$127M
AUM Growth
-$25.4M
Cap. Flow
-$2.61M
Cap. Flow %
-2.06%
Top 10 Hldgs %
26.61%
Holding
206
New
12
Increased
61
Reduced
68
Closed
20

Top Buys

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$968K
2
CLB icon
Core Laboratories
CLB
+$636K
3
C icon
Citigroup
C
+$530K
4
COIN icon
Coinbase
COIN
+$520K
5
QCOM icon
Qualcomm
QCOM
+$498K

Top Sells

Rank Stock Value
1
PETS icon
PetMed Express
PETS
+$1.15M
2
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$573K
3
RPRX icon
Royalty Pharma
RPRX
+$527K
4
CTXS
Citrix Systems Inc
CTXS
+$495K
5
ATVI
Activision Blizzard
ATVI
+$470K

Sector Composition

Rank Sector Weight
1 Financials 24.03%
2 Healthcare 13.3%
3 Technology 8.58%
4 Consumer Discretionary 7.86%
5 Industrials 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MANU icon
176
Manchester United
MANU
$3.73B
$153K 0.12%
13,744
+1,270
+10% +$16.4K
WEBR
177
DELISTED
Weber Inc.
WEBR
$85K 0.07%
+11,810
New +$98.8K
AATC
178
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
$83K 0.07%
15,185
– –
EZPW icon
179
Ezcorp Inc
EZPW
$1.71B
$75K 0.06%
+10,000
New +$72.8K
CAN
180
Canaan Creative
CAN
$159M
$63K 0.05%
19,500
– –
XXII
181
22nd Century Group
XXII
$1.48M
– –
0
– –
QRHC icon
182
Quest Resource Holding
QRHC
$31.6M
$41K 0.03%
10,000
– –
RLX icon
183
RLX Technology
RLX
$2.46B
$34K 0.03%
16,000
– –
T icon
184
CALL
AT&T
T
$163B
$3K ﹤0.01%
11,000
-3,564
-24% -$71.1K
SABR icon
185
CALL
Sabre
SABR
$835M
$1K ﹤0.01%
15,000
– –
TEVA icon
186
CALL
Teva Pharmaceuticals
TEVA
$41.2B
$1K ﹤0.01%
15,000
– –
AEM icon
187
Agnico Eagle Mines
AEM
$90.5B
– –
-3,274
Closed -$200K
ALL icon
188
Allstate
ALL
$67.5B
– –
-2,504
Closed -$347K
BAC icon
189
Bank of America
BAC
$442B
– –
-5,492
Closed -$226K
BNS icon
190
Scotiabank
BNS
$108B
– –
-3,082
Closed -$221K
CCLD icon
191
CareCloud
CCLD
$112M
– –
-55,000
Closed -$283K
CVGW
192
DELISTED
Calavo Growers
CVGW
– –
-9,777
Closed -$356K
EA
193
DELISTED
Electronic Arts
EA
– –
-1,842
Closed -$233K
IFF icon
194
International Flavors & Fragrances
IFF
$21.9B
– –
-1,661
Closed -$218K
IMNM icon
195
Immunome
IMNM
$2.83B
– –
-28,013
Closed -$159K
INFY icon
196
Infosys
INFY
$50.7B
– –
-8,681
Closed -$216K
MFIN icon
197
Medallion Financial
MFIN
$250M
– –
-25,348
Closed -$215K
NFLX icon
198
Netflix
NFLX
$309B
– –
-6,740
Closed -$252K
PETS icon
199
PetMed Express
PETS
$42.3M
– –
-44,581
Closed -$1.15M
TRV icon
200
Travelers Companies
TRV
$80.2B
– –
-1,114
Closed -$204K
5 6 7
8
9

Similar funds

IP
Indigo Partners Phoenix, Arizona $267M AUM 9% 1-Year Est. Return
CFG
Cambridge Financial Group Columbus, Ohio $267M AUM 31.62% 1-Year Est. Return
EU
Emory University Atlanta, Georgia $267M AUM 48.26% 1-Year Est. Return
PC
Packer & Co Cottesloe, Australia $267M AUM
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
TWM
TCFG Wealth Management Laguna Niguel, California $267M AUM 39.78% 1-Year Est. Return
SP
ShawSpring Partners Boston, Massachusetts $268M AUM 28.19% 1-Year Est. Return
EAIC
Empower Annuity Insurance Company Hartford, Connecticut $268M AUM 0.28% 1-Year Est. Return

Ridgewood Investments's Q2 2022 Portfolio in Review

As of Q2 2022, Ridgewood Investments held 206 positions worth $127M, down 17% from $152M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ridgewood Investments's Q2 2022 filing shows 12 new, 61 increased, 68 reduced and 20 closed positions. Its largest new stake was Organon & Co: 27,648 shares worth $933K. The largest sale was PetMed Express, an estimated $1.15M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.

  • Ridgewood Investments's largest Q2 2022 buy was Organon & Co: 27,648 shares worth $933K.
  • Ridgewood Investments added most to Citigroup in Q2 2022, an estimated $530K increase.
  • Ridgewood Investments's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $527K.
  • Ridgewood Investments fully exited PetMed Express in Q2 2022, selling an estimated $1.15M.
  • Ridgewood Investments's ten largest holdings make up 27% of its $127M portfolio in Q2 2022.
  • Ridgewood Investments opened 12 new positions and closed 20 in Q2 2022.
  • Ridgewood Investments's portfolio value fell 17% quarter-over-quarter to $127M.

Based on Ridgewood Investments's 13F filing for Q2 2022, filed 19 Jul 2022.